BioStem Technologies (BSEM) Stock Price, News & Analysis

Company Overview

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

Key Stats

• Today's Range: $11.85 to $14.87
• 50-Day Range: $7.58 to $15.37
• 52-Week Range: $6.77 to $28.26
• Volume: 203,753 shs
• Average Volume: 67,702 shs
• Market Capitalization: $242.69 million
• P/E Ratio: 21.37
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BSEM Stock Analysis - Frequently Asked Questions

How have BSEM shares performed this year?

BioStem Technologies' stock was trading at $13.84 on January 1st, 2025. Since then, BSEM shares have increased by 5.0% and is now trading at $14.53.
View the best growth stocks for 2025 here.

How were BioStem Technologies' earnings last quarter?

BioStem Technologies, Inc. (OTCMKTS:BSEM) issued its quarterly earnings results on Tuesday, November, 12th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.31 by $0.01. The firm had revenue of $82.56 million for the quarter, compared to analysts' expectations of $78.22 million.
Read the conference call transcript.

How do I buy shares of BioStem Technologies?

Shares of BSEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BioStem Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BioStem Technologies investors own include NVIDIA (NVDA), Tesla (TSLA), Broadcom (AVGO), Advanced Micro Devices (AMD), SoFi Technologies (SOFI) and Energy Transfer (ET).

Company Calendar

• Last Earnings: 11/12/2024
• Today: 4/25/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BSEM
• Previous Symbol: OTCMKTS:BSEM
• CIK: 1658678
• Web: www.biostemtechnologies.com
• Phone: 954-380-8342
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 21.37
• Forward P/E Ratio: 10.30
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $16.68 million
• Price / Sales: 14.55
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 16,703,000
• Free Float: N/A
• Market Cap: $242.69 million
• Optionable: N/A
• Beta: 0.09